You are here

Applied Stemcell, Inc.

Company Information
Address
521 Cottonwood Dr Ste 111
Milpitas, CA 95035-7467
United States


http://www.appliedstemcell.com

Information

DUNS: 956538677

# of Employees: 30


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: Yes



Award Charts




Award Listing

  1. Targeted Gene Insertion by Directed Evolution of ΦC31 Integrase for Therapeutic Gene Editing

    Amount: $224,854.00

    Pain Point: Applied StemCell (ASC) is engineering ΦC31 integrase through directed evolution to establish the ability to site-specifically integrate exogenous DNA into the human genome. Currently, the ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  2. Targeted Gene Insertion by Directed Evolution of ΦC31 Integrase for Therapeutic Gene Editing

    Amount: $1,116,010.00

    Pain Point: Applied StemCell (ASC) is engineering ΦC31 integrase through directed evolution to establish the ability to site-specifically integrate exogenous DNA into the human genome. Currently, the ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  3. Development of Cre driver rat strains for creating conditional and physiologically relevant models of human diseases

    Amount: $1,282,596.00

    The goal of this proposal is to establish a Cre loxP rat resource for conditional and physiologically predictive rat models of human diseasesThe laboratory ratRnorvegicusis a central experimental anim ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  4. improving Cas9 mediated homologous recombination in pluripotent stem cells

    Amount: $224,518.00

    DESCRIPTION provided by applicant Gene correction therapy is one of the most important application directions in regenerative medicine Scientists are exploring various approaches to introduce targ ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  5. Development of novel rat models for site-specific transgene integration

    Amount: $217,900.00

    The goal of this proposal is to develop novel rat strains that can be used to efficiently generate site-specific transgenic rat models via pronuclear microinjection. The laboratory rat (R. norvegicus) ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  6. Modernize animal pharming with emerging gene targeting technologies

    Amount: $186,180.00

    DESCRIPTION (provided by applicant): Animal pharming is the process of using transgenic animals to produce human drugs, mostly in the mammary glands of female animals. The US Food and Drug Administra ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government